Literature DB >> 18975328

Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions.

Anne Waschbisch1, Sabine Wintterle, Hanns Lochmüller, Maggie C Walter, Jörg Wischhusen, Bernd C Kieseier, Heinz Wiendl.   

Abstract

OBJECTIVE: Interactions between the family of B7 ligands and their receptors are increasingly recognized as crucial for stimulation and/or inhibition of immune responses. The present study was undertaken to examine the expression and functional relevance of B7 homolog 3 (B7-H3), a novel B7 homolog attributed significant immunoregulatory functions, in human muscle cells in vivo and in vitro.
METHODS: Thirty-five muscle biopsy specimens obtained from patients with polymyositis, dermatomyositis, inclusion body myositis, or noninflammatory myopathies and normal controls were analyzed by immunohistochemistry for B7-H3 expression. The expression of B7-H3 protein on primary human myoblasts and TE671 muscle rhabdomyosarcoma cells was studied by flow cytometry and Western blot analysis. B7-H3 small interfering RNA (siRNA) was used to study the impact of knockdown of B7-H3 on CD8+ cell-mediated lysis in skeletal muscle cells.
RESULTS: B7-H3 was not detectable on normal muscle fibers. In contrast, its expression was markedly increased on muscle fibers from patients with inflammatory myopathies. Cell-surface staining was most prominent in the contact areas between muscle fibers and inflammatory cells. B7-H3 protein was detected on myoblasts cultured from control and myositis patient muscle tissue as well as in TE671 muscle rhabdomyosarcoma cells. Knockdown of B7-H3 by siRNA in TE671 cells enhanced CD8+ T cell-specific lysis, indicating a functional role of B7-H3 in the protection of skeletal muscle from immune-mediated lysis.
CONCLUSION: Our results demonstrate that human muscle cells express B7-H3, a functional coinhibitory molecule of the B7 family. B7-H3 may play an important role in muscle-immune interactions, providing further evidence of the active role of muscle cells in local immunoregulatory processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18975328     DOI: 10.1002/art.23997

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.

Authors:  Hiroko Kobori; Masaaki Hashiguchi; Jinhua Piao; Moriyuki Kato; Patcharee Ritprajak; Miyuki Azuma
Journal:  Immunology       Date:  2010-02-05       Impact factor: 7.397

Review 2.  Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis.

Authors:  Andrea Henriques-Pons; Kanneboyina Nagaraju
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006

3.  Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.

Authors:  Chompoonuch Sawaengsak; Yasuko Mori; Koichi Yamanishi; Ampol Mitrevej; Nuttanan Sinchaipanid
Journal:  AAPS PharmSciTech       Date:  2013-12-17       Impact factor: 3.246

4.  Treatment of inclusion body myositis: is low-dose intravenous immunoglobulin the solution?

Authors:  Mike Recher; Ulrike Sahrbacher; Juliane Bremer; Börge Arndt; Urs Steiner; Adriano Fontana
Journal:  Rheumatol Int       Date:  2010-01-01       Impact factor: 2.631

5.  [New aspects on the pathogenesis of myositis].

Authors:  B Stuhlmüller; E Feist; T Häupl; G-R Burmester; N Pipitone
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

6.  Upregulation of the B7/CD28 family member B7-H3 in bladder cancer.

Authors:  Deyao Wu; Zichun Zhang; Huixing Pan; Yuanfeng Fan; Ping Qu; Jian Zhou
Journal:  Oncol Lett       Date:  2014-12-23       Impact factor: 2.967

Review 7.  Immune and myodegenerative pathomechanisms in inclusion body myositis.

Authors:  Christian W Keller; Jens Schmidt; Jan D Lünemann
Journal:  Ann Clin Transl Neurol       Date:  2017-05-16       Impact factor: 4.511

Review 8.  Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?

Authors:  Michael Kuske; Maximilian Haist; Thomas Jung; Stephan Grabbe; Matthias Bros
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

Review 9.  Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis.

Authors:  Abhirami K Iyer; Kathryn J Jones; Virginia M Sanders; Chandler L Walker
Journal:  Int J Mol Sci       Date:  2018-02-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.